NIDA Clinical Trials Network CTN-0051, Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment (X:BOT): Study design and rationale - Concepedia

Concepedia

Publication | Open Access

NIDA Clinical Trials Network CTN-0051, Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment (X:BOT): Study design and rationale

DOI Full Paper Access

60

Citations

40

References

2016

Year

Joshua D. Lee, Edward V. Nunes, Patricia Novo, Genie L. Bailey, Gregory S. Brigham, Allan Cohen, Marc Fishman, Walter Ling, Robert Lindblad, Dikla Shmueli‐Blumberg,

Contemporary Clinical Trials

Extended-release NaltrexoneOpioid EpidemicSubstance AbuseStudy DesignOpioid TreatmentAddiction TreatmentPain MedicineAddictionPharmacologyClinical TrialsAddiction MedicinePharmacotherapyPain ManagementDrug TreatmentMedicineHarm ReductionOpioid Use DisorderHealth Sciences

References

	Year	Citations

Page 1

Page 1